US Stock MarketDetailed Quotes

CDLA Candela Medical

Watchlist

0.000
0.0000.00%

Close Sep 12 09:30 ET

0Market Cap0.00P/E (TTM)

Candela Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Total revenue

-17.48%321.65M

389.77M

Operating revenue

-17.48%321.65M

--389.77M

Cost of revenue

-17.21%182.57M

220.52M

Gross profit

-17.83%139.08M

169.25M

Operating expense

-17.46%159.12M

192.77M

Selling and administrative expenses

-18.35%135.59M

--166.07M

-Selling and marketing expense

-30.69%85.74M

--123.7M

-General and administrative expense

17.66%49.85M

--42.37M

Research and development costs

-11.89%23.53M

--26.7M

Operating profit

14.79%-20.04M

-23.52M

Net non-operating interest income expense

-365.02%-12.43M

-2.67M

Non-operating interest expense

365.02%12.43M

--2.67M

Other net income (expense)

-672.66%-2.97M

-384K

Gain on sale of security

-760.24%-3.53M

---410K

Special income (charges)

38.36%-810K

---1.31M

-Gain on sale of property,plant,equipment

38.36%-810K

---1.31M

Other non- operating income (expenses)

2.24%1.37M

--1.34M

Income before tax

-33.34%-35.44M

-26.58M

Income tax

1.70%8.45M

8.31M

Net income

-25.80%-43.89M

-34.89M

Net income continuous Operations

-25.80%-43.89M

---34.89M

Minority interest income

Net income attributable to the parent company

-25.80%-43.89M

-34.89M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-25.80%-43.89M

-34.89M

Basic earnings per share

-25.74%-0.449

-0.3571

Diluted earnings per share

-25.74%-0.449

-0.3571

Dividend per share

Currency Unit

USD

USD

Audit Opinions

Unqualified Opinion

--

	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Total revenue	-17.48%321.65M	389.77M
Operating revenue	-17.48%321.65M	--389.77M
Cost of revenue	-17.21%182.57M	220.52M
Gross profit	-17.83%139.08M	169.25M
Operating expense	-17.46%159.12M	192.77M
Selling and administrative expenses	-18.35%135.59M	--166.07M
-Selling and marketing expense	-30.69%85.74M	--123.7M
-General and administrative expense	17.66%49.85M	--42.37M
Research and development costs	-11.89%23.53M	--26.7M
Operating profit	14.79%-20.04M	-23.52M
Net non-operating interest income expense	-365.02%-12.43M	-2.67M
Non-operating interest expense	365.02%12.43M	--2.67M
Other net income (expense)	-672.66%-2.97M	-384K
Gain on sale of security	-760.24%-3.53M	---410K
Special income (charges)	38.36%-810K	---1.31M
-Gain on sale of property,plant,equipment	38.36%-810K	---1.31M
Other non- operating income (expenses)	2.24%1.37M	--1.34M
Income before tax	-33.34%-35.44M	-26.58M
Income tax	1.70%8.45M	8.31M
Net income	-25.80%-43.89M	-34.89M
Net income continuous Operations	-25.80%-43.89M	---34.89M
Minority interest income
Net income attributable to the parent company	-25.80%-43.89M	-34.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-25.80%-43.89M	-34.89M
Basic earnings per share	-25.74%-0.449	-0.3571
Diluted earnings per share	-25.74%-0.449	-0.3571
Dividend per share
Currency Unit	USD	USD
Audit Opinions	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall